Pomegranate juice polyphenols induce a phenotypic switch in macrophage polarization favoring a M2 anti-inflammatory state

BioFactors

Volumn 41, Issue 1, 2015, Pages 44-51

  Aharoni, Saar ^a   Lati, Yoni ^a   Aviram, Michael ^a   Fuhrman, Bianca ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Inflammation; M1 M2 activation; Macrophages; Polyphenols; Pomegranate juice

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE II; ELLAGIC ACID; GALLIC ACID; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; POLYPHENOL DERIVATIVE; POMEGRANATE EXTRACT; PUNICALAGIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ARG1 PROTEIN, MOUSE; ARG2 PROTEIN, MOUSE; GAMMA INTERFERON; IL10 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; IN VITRO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; POMEGRANATE JUICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; BEVERAGE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYTHRACEAE; OXIDATIVE STRESS; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION;

LYTHRACEAE; MUS;

AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTA; ARGINASE; BEVERAGES; CELL LINE; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; OXIDATIVE STRESS; PLAQUE, ATHEROSCLEROTIC; PUNICACEAE; SIGNAL TRANSDUCTION;

EID: 84923625023     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1199     Document Type: Article

References (27)

1. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126.
2. Mosser, D. M., and Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 8, 958-969.
3. Martinez, F. O., Sica, A., Mantovani, A., and Locati, M. (2008) Macrophage activation and polarization. Front Biosci. 13, 453-461.
4. Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., et al. (2007) PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137-143.
5. Mantovani, A., Garlanda, C., and Locati, M. (2009) Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 29, 1419-1423.
6. Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A. T., et al. (2010) Macrophage plasticity in experimental atherosclerosis. PLoS One 25, 8852.
7. Biesalski, H. K. (2007) Polyphenols and inflammation: basic interactions. Curr. Opin. Clin. Nutr. Metab. Care 10, 724-728.
8. Santangelo, C., Varì, R., Scazzocchio, B., Di Benedetto, R., Filesi, C., et al. (2007) Polyphenols, intracellular signalling and inflammation. Ann. Ist. Super. Sanita. 43, 394-405.
9. Gil, M. I., Tomás-Barberán, F. A., Hess-Pierce, B., Holcroft, D. M., and Kader, A. A. (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48, 4581-4589.
10. Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., et al. (2000) Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 71, 1062-1076.
11. Jung, K. H., Kim, M. J., Ha, E., Uhm, Y. K., Kim, H. K., et al. (2006) Suppressive effect of Punica granatum on the production of tumor necrosis factor (Tnf) in BV2 microglial cells. Biol. Pharm. Bull. 29, 1258-1261.
12. Hollebeeck, S., Winand, J., Hérent, M. F., During, A., Leclercq, J., et al. (2012) Anti-inflammatory effects of pomegranate (Punica granatum L.) husk ellagitannins in Caco-2 cells, an in vitro model of human intestine. Food Funct. 3, 875-885.
13. Xu, X., Yin, P., Wan, C., Chong, X., Liu, M., et al. (2014) Punicalagin inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPKs and NF-κB activation. Inflammation 37, 956-965.
14. Balbir-Gurman, A., Fuhrman, B., Braun-Moscovici, Y., Markovits, D., and Aviram, M. (2011) Consumption of pomegranate decreases serum oxidative stress and reduces disease activity in patients with active rheumatoid arthritis: a pilot study. Isr. Med. Assoc. J. 13, 474-479.
15. Shema-Didi, L., Sela, S., Ore, L., Shapiro, G., Geron, R., et al. (2012) One year of pomegranate juice intake decreases oxidative stress, inflammation, and incidence of infections in hemodialysis patients: a randomized placebo-controlled trial. Free Radic. Biol. Med. 53, 297-304.
16. Rojanathammanee, L., Puig, K. L., and Combs, C. K. (2013) Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J. Nutr. 143, 597-605.
17. Bachoual, R., Talmoudi, W., Boussetta, T., Braut, F., and El-Benna, J. (2011) An aqueous pomegranate peel extract inhibits neutrophil myeloperoxidase in vitro and attenuates lung inflammation in mice. Food Chem. Toxicol. 49, 1224-1228.
18. Khan, N., Syed, D. N., Pal, H. C., Mukhtar, H., and Afaq, F. Pomegranate fruit extract inhibits UVB-induced inflammation and proliferation by modulating NF-κB and MAPK signaling pathways in mouse skin. Photochem. Photobiol. 88, 1126-1134.
19. Al-Jarallah, A., Igdoura, F., Zhang, Y., Tenedero, C. B., White, E. J., et al. (2013) The effect of pomegranate extract on coronary artery atherosclerosis in SR-BI/APOE double knockout mice. Atherosclerosis 228, 80-89.
20. Kaplan, M., Hayek, T., Raz, A., Coleman, R., Dornfeld, L., et al. (2001) Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J. Nutr. 131, 2082-2089.
21. Rosenblat, M., Volkova, N., Coleman, R., and Aviram, M. (2006) Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein. J. Agric. Food Chem. 54, 1928-1935.
22. Kroes, B. H., van den Berg, A. J., Quarles van Ufford, H. C., van Dijk, H., and Labadie, R. P. (1992) Anti-inflammatory activity of gallic acid. Planta Med. 58, 499-504.
23. Lee, W. J., Ou, H. C., Hsu, W. C., Chou, M. M., Tseng, J. J., et al. (2010) Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J. Vasc. Surg. 52, 1290-1300.
24. Seeram, N. P., Adams, L. S., Henning, S. M., Niu, Y., Zhang, Y., et al. (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J. Nutr. Biochem. 16, 360-367.
25. Cerdá, B., Llorach, R., Cerón, J. J., Espín, J. C., and Tomás-Barberán, F. A. (2003) Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur. J. Nutr. 42, 18-28.
26. Cerdá, B., Espín, J. C., Parra, S., Martínez, P., and Tomás-Barberán, F. A. (2004) The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur. J. Nutr. 43, 205-220.
27. Larrosa, M., Tomás-Barberán, F. A., and Espín, J. C. (2006) The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J. Nutr. Biochem. 17, 611-625.